COMMUNIQUÉS West-GlobeNewswire

LIDDS participates at Redeye Life Science Day
16/11/2018
The Life Science Event takes place at Haymarket by Scandic on November 21. CEO Monica Wallter will present the company and update the audience on the latest developments of the NanoZolid technology platform. The LIDDS [...]
LIDDS presence at BIO-Europe 2018 to focus on NanoZolid's broad drug formulation capability
16/11/2018
The Life Science Event takes place at Haymarket by Scandic on November 21. CEO Monica Wallter will present the company and update the audience on the latest developments of the NanoZolid technology platform. The LIDDS [...]
Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Ilixadencel in Combination with Avelumab in Multi-Indication Phase Ib/II Study
16/11/2018
Press Release 16 November 2018 Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Ilixadencel in Combination with Avelumab in Multi-Indication Phase Ib/II Study [...]
ReWalk Robotics Announces Pricing of $11.6 Million Public Offering
16/11/2018
YOKNEAM ILIT, ISRAEL and MARLBOROUGH, Mass., Nov. 16, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the pricing of an underwritten public offering of 38,660 [...]
Xbrane Biopharma releases interim report for the third quarter of 2018
16/11/2018
Press release 2018-11-16 Xbrane Biopharma AB's (publ.) ("Xbrane") interim report for the third quarter of 2018 is now available on the Company's website, www.xbrane.com . Financial summary third quarter 2018 Revenue [...]
Rule 2.9 Announcement
16/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 16 November 2018 [...]
Chi-Med Announces Phase III FALUCA Trial Results for Fruquintinib in Third-Line, Advanced Non-Small Cell Lung Cancer in China
16/11/2018
– Trial did not meet the primary endpoint of overall survival despite improvement in progression-free survival – LONDON, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) [...]
Shire Announces New HELP Study(TM) Data for Lanadelumab in HAE at 2018 ACAAI Annual Scientific Meeting
16/11/2018
Shire Announces New HELP Study™ Data for Lanadelumab in Hereditary Angioedema (HAE) at 2018 ACAAI Annual Scientific Meeting - Data shows lanadelumab provides significant, clinically meaningful reduction of HAE attacks [...]
DBV Technologies Appoints Daniel Tassé as Chief Executive Officer
16/11/2018
Montrouge, France, November 16, 2018 DBV Technologies Appoints Daniel Tassé as Chief Executive Officer Daniel brings strong track record of building and leading global organizations and delivering transformative [...]
DBV Technologies nomme Daniel Tassé au poste de Directeur Général
16/11/2018
Montrouge, France, le 16 novembre (07h30 CET), 2018 DBV Technologies nomme Daniel Tassé au poste de Directeur Général M. Tassé possède une solide expérience dans la direction de sociétés pharmaceutiques globales et dans [...]
TOMI Environmental Solutions, Inc. Announces Milestone With Record Revenue in the Third Quarter
16/11/2018
BEVERLY HILLS, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global provider of infection prevention and decontamination products, services and research, including [...]
Childhood Obesity Foundation applauds recommendation to apply PST to Sugary Drinks
15/11/2018
VANCOUVER, British Columbia, Nov. 15, 2018 (GLOBE NEWSWIRE) -- BC’s Select Standing Committee on Finance and Government Services’ report today recommends once again that PST be applied to sugary drinks. This is a step [...]
Mesoblast Reports First Quarter Ended September 30, 2018 Financial Results and Operational Highlights
15/11/2018
MELBOURNE, Australia and NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today reported strong financial results and provided operational highlights for the first quarter ended [...]
Viveve Named One of North America’s 500 Fastest Growing Companies by Deloitte
15/11/2018
Company awarded sixth place overall and is only medical device company listed in the top ten ENGLEWOOD, Colo., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused [...]
The Cooper Companies to Participate in the BMO Healthcare Conference
15/11/2018
PLEASANTON, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the BMO Prescriptions for Success Healthcare Conference in New York, NY, on December 12, 2018. Brian G. [...]
Equillium Reports Third Quarter 2018 Financial Results and Recent Highlights
15/11/2018
Completes Successful Initial Public Offering Raising Gross Proceeds of Approximately $71.6 Million On-Track for Early 2019 Initiation of Phase 1b/2 Trial of EQ001 in Acute Graft-Versus-Host Disease LA JOLLA, Calif., Nov [...]
ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research
15/11/2018
LYON, France and CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug [...]
ERYTECH s’associe au New York Blood Center pour l’approvisionnement et la recherche sur les globules rouges
15/11/2018
LYON, France et CAMBRIDGE, Mass., 15 nov. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris : ERYP - Nasdaq : ERYP), société biopharmaceutique de stade clinique développant des thérapies innovantes par [...]
National Brain Tumor Society CEO Receives Inaugural Community Service Award at Society of Neuro-Oncology Annual Meeting
15/11/2018
Boston, MA, Nov. 15, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced that its Chief Executive Officer, [...]

Pages